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Oral Pre-Exposure Prophylaxis (PrEP) is an effective HIV prevention strategy for adherent
users. Adolescent girls and young women (AGYW) in sub-Saharan Africa may particularly
benefit from PrEP because of the disproportionate burden of HIV in this group. Understand-
ing potential users’ perceptions of and interest in using PrEP is critical to promote the utiliza-
tion of PrEP by individuals at risk of HIV.
Methods
This qualitative investigation of AGYW’s knowledge of and interest in PrEP use was con-
ducted in the context of Girl Power, a quasi-experimental cohort study comparing four mod-
els of service delivery at four health centers in Lilongwe, Malawi. We conducted individual
in-depth interviews (IDIs) with 40 HIV-negative AGYW ages 15–24 years old six months
after enrolment in the parent study. An explanation of PrEP was provided to participants.
Interview topics included participants’ prior knowledge of, interest in, concerns about, and
delivery preferences for PrEP. Analysis consisted of structural coding of interview tran-
scripts corresponding to interview topics, summary of responses within these topics, and
identification and description of emerging themes within each topic.
Results
None of the AGYW had knowledge of PrEP prior to the IDIs, but once explained, a majority
expressed an interest in using it due to inconsistencies in condom use, condom use errors,
their own or their partners’ concurrent sexual partnerships, and rape. Most AGYW hoped
that PrEP would be available in youth-friendly sections of health centers for easy access
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and youth-friendly counselling. They suggested that discrete packaging of PrEP would be
needed to ensure user privacy. Concerns about relationship destabilization and accusations
of promiscuity were raised as potential barriers to use.
Conclusion
General interest in PrEP among AGYW was high. Discrete packaging and access to youth-
friendly PrEP delivery modalities may facilitate the utilization of PrEP as a prevention strat-
egy among sexually active AGYW. Attention to potential negative reactions from partners
and community members to PrEP use will be needed when introducing PrEP to this
population.
Introduction
In the past three decades, many populations in sub-Saharan Africa have been greatly impacted
by the HIV epidemic, and adolescent girls and young women (AGYW) are no exception.
Young women are at very high risk of acquiring HIV [1,2]; In Malawi, new HIV infections
among AGYW ages 15–24 are more than twice those among young men of the same age [3,4].
Approximately 12,500 new HIV infections occur among young people ages 15–24 years annu-
ally; 70 percent of these new HIV infections are among young women [5]. AGYW in this con-
text remain at elevated risk for infection due to biological, social, and behaviour factors[5].
While effective strategies exist to promote the use of condoms [6], condom use is primarily
male-controlled and often affords women only a limited ability to protect their sexual health
because of the need to negotiate condom use with their sexual partners.
Oral Pre-Exposure Prophylaxis (PrEP), an effective user-controlled method of HIV preven-
tion, holds great promise for this population. Oral PrEP, the use of combination antiretroviral
therapy for HIV prevention, is 90% effective in preventing HIV when taken with good adher-
ence [7,8],. Because PrEP pill-taking is self-controlled and requires no specific action or nego-
tiation at the time of sex, this method holds particular promise as an HIV prevention method
for AGYW who may have limited powers to negotiate condom use.
World Health Organization (WHO) guidelines recommended PrEP use among at-risk pop-
ulations worldwide including AGYW in high burden settings [9]. Following the WHO recom-
mendation, many countries including Malawi are beginning to pilot implementation of PrEP
to AGYW and other key populations. As Malawi introduces PrEP to this important popula-
tion, we need to understand more about AGYW’s potential interest in and for PrEP use to
inform the delivery of this new prevention method. To this end, we conducted a qualitative
study to understand knowledge of, interest in, concerns about, and delivery preferences for
PrEP among sexually active AGYW enrolled in a prospective study investigating models of
AGYW service delivery in Lilongwe, Malawi. With this information, we hope to understand
how to tailor PrEP education and delivery to inform the successful rollout of PrEP to this vul-
nerable population in Malawi and similar settings.
Methods
Study context
The data presented here were collected in the context of Girl Power, a quasi-experimental
cohort study comparing four models of service delivery at four health centers in Lilongwe,
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conducted between February 2016 and August 2017. Sexually active AGYW ages 15–24 years
were enrolled in the parent study [10,11]. Four models of service-delivery were compared in
four separate clinics: Model 1) standard of care, Model 2) Integrated youth-friendly health ser-
vices; Model 3) Model 2 plus a small-group behavioral intervention on various health and
social topics; and Model 4) Model 3 plus a cash transfer ($5.50/month) that was conditional on
attending each behavioral intervention session. The Girl Power intervention clinics (Models
2–4) offered a range of sexual reproductive health services (SRH) that were integrated, offered
in youth-dedicated areas, and staffed by providers trained in youth-friendly health services.
The services included: HIV testing, syndromic management of sexually transmitted infections
(STI), family planning, and condom distribution. These services were offered to all AGYW
regardless of their eligibility to participate in the study. The main trial results have been pub-
lished previously [10, 11]. PrEP was not provided in this study, nor was it available in govern-
ment clinics at the time of the study.
AGYW were eligible to participate if they were 15–24 years old, from the clinics’ catchment
areas, and willing to provide locator information. Sexually active AGYW were purposively
recruited from urban and semi urban clinic defined catchment areas through a combination
of community outreach, participant referral, and self-referral. Community outreach consisted
of peer educators visiting socioeconomically disadvantaged parts of the catchment area. They
engaged AGYW in one-on-one conversations about what study participation entailed. AGYW
who enrolled were then provided with 3 invitations to invite friends (participant referral).
AGYW who learned of the study through other sources in the communities such as or friend,
could also enroll (self-referral). Recruitment from within the clinic itself was discouraged in
order to prevent selection biases. One thousand participants ages 15–24 years old who
reported being sexually active and living within the study clinic catchment area were enrolled
in the trial, with 250 participants from each health facility.
Qualitative study participants and procedures
The qualitative sub-study presented here was undertaken to elicit participants’ opinions and
perceptions of PrEP and its delivery if it were to be implemented in Malawi. We aimed to
answer three primary research questions through these interviews: 1) What are the reasons for
which AGYWmight be interested in using PrEP?; 2) What are the reasons for which AGYW
might be concerned about using PrEP?; 3) What methods and features of PrEP delivery are
important to the acceptability of PrEP among AGYW? Because many at-risk AGYW may not
be highly engaged in healthcare, we sought to understand whether PrEP interest and prefer-
ences for delivery would differ by high-engagement (“good care-seekers”), and low-engage-
ment (“poor care seekers”) and also to make sure we were not selectively getting responses
from good care-seekers. Both groups’ interests will have an impact on considering future PrEP
implementation and management of programs tailored to AGYW health seeking behaviours.
To understand these issues by level of healthcare engagement, we purposively sampled 40 qual-
itative study participants who were classified as good care-seekers (N = 20) or poor-care-seek-
ers (N = 20). The level of care seeking was based on data from monthly or quarterly visits
schedules for care services they received within the past 6 months in the Girl Power study. We
purposely sampled 10 participants from each of the four study clinics: five good care seekers
and five poor care seekers. We defined good care seekers as participants who obtained multiple
services in the past 6 months, while poor care seekers were those who enrolled and received
one or no services in the past 6 months. All 40 participants recruited for interview were sexu-
ally active.
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Data collection
Individual in-depth interviews (IDIs) with the 40 participants occurred between November
2016 and February 2017. All participants completed informed consent in the main study prior
to the interview. Malawian qualitative research specialists trained in qualitative research meth-
ods and fluent in both English and Chichewa, the local language, carried out qualitative inter-
views. The IDIs were conducted in Chichewa using a semi-structured interview guide, and
took place in private clinic locations where conversations could not be overheard. PrEP was
explained briefly during the in-depth interviews. To start, the interviewer introduced PrEP by
asking participants if they had previously heard of PrEP and then provided an explanation of
PrEP as follows:
“PrEP is a way for people who do not have HIV to prevent it. PrEP are pills you take every day
that contain some of the same medicine used to treat people who already have HIV. If you
have PrEP medicine in your body and you are exposed to the HIV virus, the PrEP medicine in
your body will stop the virus from being able to multiply in your body. People who are HIV-
positive cannot take PrEP instead of ARVs and people who are HIV-negative cannot take
ARVs instead of PrEP.”
Interview topics corresponding to the research questions stated above pertained to women’s
interest in, concerns about, and delivery preferences for PrEP. Specific interview questions
for each of these topics are listed in Table 1. Neutral probes were used to gather detailed
responses and elicit illustrative examples where necessary. This gave the participant the
chance to elaborate on information that she felt important to tell the interviewer. Conversa-
tions were audio-recorded with permission to ensure all data were captured verbatim. Each
interview contained additional general questions about sexual behaviour and care seeking, not
reflected in this analysis, and typically lasted one hour (60 minutes). A small incentive ($3) was
provided at the six-month study visit, when the IDIs were conducted. Following each inter-
view, the research specialist wrote a summary of the interview and shared this with the PI. This
allowed for routine debriefing in order to identify emerging themes. Later, a team of research
assistants transcribed each interview directly into English translating from Chichewa audio
recordings.
Table 1. Research and interview questions.
Research Question Interview Questions
1) What are the reasons for which AGYW might be interested
in using PrEP?
- How interested would you be in PrEP if it
were available? Why?
- What about it would be appealing to you?
- How would it compare to using male
condoms?
2) What are the reasons for which AGYW might be concerned
about using PrEP?
- Are there any reasons you would be
concerned about using PrEP?
- How might using PrEP affect your romantic
relationships?
- Would you still be interested if you
experienced side effects, like dizziness?
3) What methods and features of PrEP delivery are important
to the acceptability of PrEP among AGYW?
- How would you prefer that PrEP be packaged?
- Where would you prefer to receive PrEP? At a
Girl Power clinic? Elsewhere?
- What type of support would you want to help
you take PrEP daily?
https://doi.org/10.1371/journal.pone.0226062.t001
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Data analysis
We began analysis of the interviews by reading the summaries and full transcripts until we
became familiar with their content. We developed a codebook beginning with structural codes
corresponding to each interview topic and adding codes representing emerging themes identi-
fied through an iterative process: Participant responses were summarized within each topic
and themes were noted within topics; codes corresponding to each emergent theme were
applied to the data and the content relevant to each theme was summarized and sub-themes
were noted [12]. Thematic codes were discussed with the full research team until consensus
was reached for all codes. Each transcript was double-coded to ensure quality and consistency
using NVivo version 11 software. We used Cohen’s Kappa to measure interrater reliability. All
transcripts were double coded by two independent coders the researcher and coding com-
pared. For transcripts with less than 80% agreement we reviewed the discrepancies together
and re-coded. Responses relating to each interview topic and emerging theme were summa-
rized across participants and differences between individuals and among sub-groups of partic-
ipants were noted.
Ethical considerations
Prior to the implementation of the study, the study team obtained approval from University of
North Carolina Chapel Hill Institutional Review Board and the Malawi National Health Sci-
ences Research Committee. Written, informed consent to participate in an IDI was obtained
from all participants age 18 and above on entry to the parent study. For participants consid-
ered minors from age 15 to 17, assent was obtained from the minor and informed consent was
also obtained from a parent or authorized community representative. Participants were
reminded about content of the consent prior to the in-depth interview to ascertain their
understanding and willingness to participate in the interview. To preserve participant confi-
dentiality, anonymous unique participant identification numbers were used throughout the
study.
Results
Forty HIV-negative AGYW ages 15–24 participated in an in-depth interview. Table 2 below
describes the characteristics of the IDI participants. The majority of women interviewed were
unmarried and most had at least completed primary school education. About half had a previ-
ous pregnancy and most participants reported previous condom use. Though we anticipated
differences in the domains of interest between high-engagement and low-engagement partici-
pants and preferences in accessing PrEP, no differences were observed.
AGYW’s Knowledge of PrEP
When asked if they had ever heard of PrEP, all participants had no prior knowledge of PrEP.
The interviewer ensured that participants demonstrated an understanding of PrEP before con-
tinuing with questions regarding the potential use of PrEP.
This quote below is a representative of participants’ level of understanding on PrEP follow-
ing the explanation.
“. . .you have said that one is supposed to take this pill every day before she is exposed [sex]
and it means that the time when you will be exposed you will already have the drug in your
body and the virus cannot be active in the blood . . .” (19 years old, unmarried, high
engager)
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AGYW’S interest in PrEP
Most AGYW expressed an interest in using PrEP. This interest was grounded in women’s per-
ception of the severity of HIV infection and the desire for protection against HIV.
“. . .. if I am at risk of contracting the virus, then I will not contract the virus if I am on the
drug. So I will be protected. You know how HIV/AIDS has no medicine, so it is very scary. (23
years old, unmarried, low engager)
The perceived need for constant protection against HIV was also linked to the perceived
likelihood and threat of rape for some women. Participants felt that PrEP would be the best
way to protect themselves in situations of forced sex when they would have no control over
their HIV risk exposure:
“I can feel free to take [PrEP] because you never know what you can come across. Say for exam-
ple, if thieves break in your house, it is we girls who are on a very high risk of being raped.
Thieves cannot rape your brother. So what you have explained to me about PrEP, I think it is
good to take it because you cannot contract HIV.” (18 years old, unmarried, high engager)
AGYW were also interested in PrEP for HIV risk exposures in the context of their relation-
ships. Participants discussed two primary causes of their perceived HIV risk contributing to
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their interest in PrEP: their own and their partners’ concurrent sexual relationships, and
inconsistent condom use.
Concurrency and risk for HIV
Most participants acknowledged that having multiple concurrent sexual partners could
increase their risk of contracting HIV. This participant discusses the compounded HIV risk
presented by both partner concurrency and non-condom use, demonstrating the complex risk
calculus that may be involved in the perceived need for PrEP:
“Because if I maybe, have a lot of partners, maybe someone can encourage me to say ‘I do not
want us to use a condom, let us have unprotected sex,’ so that is how I can contract diseases.”
(21 years old, unmarried, high engager)
Some AGYW also worried about their partners’ risk behaviors beyond their control.
AGYW worried that even though they themselves might be faithful to one partner, their part-
ners might have other partners. This raised their interest in using PrEP to remain protected.
One participant said:
“It [PrEP] can bring about good things. Because say in a relationship, some men go behind
their girlfriends and have another relationship with another girl or some may even go to the
extent of having sexual relations with prostitutes. So you’d be protected.”
(21 years old, unmarried, high engager)
This participant and others saw PrEP as an opportunity to be protected against this source
of HIV risk outside of their control. PrEP was seen as beneficial not only for personal protec-
tion against HIV, but also as a potential protection benefit for a sexual network, as this partici-
pant said:
“I like it [PrEP] because there are a lot of people that have numerous sexual partners and
sleep with them without condoms except maybe one partner so it would help to protect these
numerous sexual partners from getting infected.”(21 years old, unmarried, low Low
engager)
Other women discussed the anxiety of not knowing the HIV-status of their sexual partner
(s). Sex with these partners of unknown status would bring them fear and stress about con-
tracting the HIV virus. They saw PrEP as something to alleviate this stress.
“Because sometimes you can have sex with someone whose status you don’t know and that
can stress you a lot thinking that you may have contracted the virus. However, if you start tak-
ing the drugs you can just know that you are safe even if you have sex with someone who is
positive.” (22 years old, unmarried, low engager)
Inconsistent condom use and user error
Most participants discussed PrEP interest in the context of non-use or inconsistent use of
condoms. Many women found PrEP appealing because it would eliminate concerns about hav-
ing a condom available at every sexual encounter. As this 21-year-old, unmarried young
woman said: “I would be interested to use it [PrEP] because I am at risk. I may end up having
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unprotected sex with someone just because they did not have a condom.” Participants connected
these concerns about unplanned sexual encounters and the lack of condoms and resulting
HIV exposure risk to their interest in PrEP. In addition to the issue of condoms, one partici-
pant discussed user-error in condom use as motivating factor for her interest in using PrEP:
“PrEP is good, because if you might wear a condom and it gets torn without expecting it and
they can give you the virus but if you had that medication even when the condom got torn you
would not get the virus.” (23 years old, unmarried, low engager)
Participants were also interested in using PrEP because they perceived condom use to be
under the control of their male partners, who may dislike them. One 19-year-old, unmarried
participant explained: “I think the medicine is good because most men refuse to use condoms.”
The availability of PrEP would protect the AGYW under such circumstances.
One participant was interested in PrEP in the wider context of preferences for condom-less
sex. She perceived that many young people would like to use PrEP to enjoy condom-less sex
while still being protected from HIV acquisition.
“. . . a lot of youth complain about condoms, that they do not feel good when having sex. So if
they would drink the medicine accordingly they would be happy. Because they would know
they have medicine that will protect them.” (20 years old, unmarried, high engager)
Reasons for disinterest and concerns about PrEP
Participants generally expressed positive attitudes toward PrEP; only five participants out of
forty the AGYW interviewed, expressed no interest in PrEP. Typically, participants who per-
ceived themselves to be at very low HIV risk were less interested in PrEP. These participants
perceived it that being abstinent or having only one partner and being faithful to that partner
put them at a very low risk of acquiring HIV, and were disinterested in PrEP use for that rea-
son. As this 22-year-old, unmarried, low engager participant said: “I’m not interested because I
only have one partner.”
Women also had concerns that PrEP could negatively affect their social wellbeing. Chiefly,
they were concerned about partner reactions to their PrEP use, social stigma, and the need for
dual protection for pregnancy prevention if using PrEP. These concerns are discussed below.
Partner concerns
Some participants, expressed concerns about sexual partners’ potential attitudes toward their use
of PrEP, especially among married young women. They worried that partners would suspect their
women of having extra-marital affairs. In this regard, one unmarried woman explained:
“There would be problems in marriage. . .their [married women’s] partners would question
them and would suspect that they have sex with other people. Many men [may] think that
when a woman uses that drug that means she is not faithful, there is something she is doing
and she does not want to give her partner HIV, instead of understanding that the drug will
help them together.” (20 years old, unmarried, low engager)
As this woman expresses, a woman’s use of PrEP could be seen as harmful to the level of
trust in a marital relationship, implying infidelity. In the marriage context, participants
believed that a couple has to be faithful to each other, and thus women taking the initiative to
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take PrEP on their own might be seen to violate this norm. This young woman explained how
she thought this would be perceived in a marriage:
“. . . Imagine these drugs are found with a married woman, what picture is that going to give?
It may mean that there is lack of faithfulness between the two.” (18 years old, married, low
engager)
Negative community perceptions about PrEP use and side effects
Some participants were also concerned about possible community reactions to their use of
PrEP. Some women felt that people might think they are HIV positive and taking ART; this
woman explained her fear as follows.
“The fear can be there because you are supposed to take this drug daily wherever you go and
people may misinterpret it to think they are ARVs” (19 years old, unmarried, high engager)
Apart from fears of the appearance of taking a daily pill, some women were concerned
about the appearance of PrEP side effects that could be also misperceived. While most AGYW
said they would consult doctors for professional help if unacceptable side effects occurred, a
few said they would stop taking PrEP if the side effects could lead to negative perceptions by
members of the community. One woman suggested that side effects that affect your productiv-
ity or mimic pregnancy would lead to feelings of shame, stigma, and social rejection.
“. . . I would not be at peace with them [PrEP pills], because when you take something and
you start having other problems that means you won’t be able to work. What if you go to the
market and fall at the market people will be wondering if you are pregnant or what. . .” (20
years old, unmarried, low engager)
In addition to being concerned about community reactions, some women also expressed
their own stigmatizing attitudes toward PrEP use. Participants felt that the confidence in being
protected against HIV provided by PrEP would promote behaviors that they perceived as “pro-
miscuous” in users:
“What I am trying to say is that PrEP will give room to promiscuity; people on PrEP will sleep
around a lot just because they know that they have this [protection],” (18 years old, married,
low engager).
Need for dual protection
Women were also concerned that PrEP users who no longer felt the need to use condoms
would not be sufficiently protected against pregnancy and other sexually transmitted infec-
tions (STIs). They expressed the disadvantage of PrEP as compared to condoms for those
women hoping to avoid pregnancy, since both PrEP and contraception would have to be used
in combination to prevent pregnancy and HIV. One 22-year-old, unmarried, low engager
commented: “Condoms are better because with PrEP, you only protect yourself against HIV but
you can become pregnant while with condoms you are protected against both pregnancy and
infection.” The failure of PrEP to protect young women from pregnancy and other STIs, and
the burden to protect themselves against unplanned pregnancy and other STIs made women
less interested in using PrEP.
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Preferences for PrEP delivery
On balance, AGYW were generally interested in PrEP, despite the concerns expressed above.
Women, however explained that that their interest in initiating PrEP would also depend upon
the ease of accessing PrEP, packaging attributes, and delivery context. Participants commonly
held the opinion that the process of obtaining pills should be confidential and the appearance
of PrEP packaging should be discrete to avoid negative perceptions.
Packaging preferences
Participants shared a variety of ideas for PrEP packaging that would boost their interest. They
favored PrEP to be packaged in cartons, packets, or bottles that would give the appearance of
medications for common ailments. Particularly, AGYW emphasized that PrEP packaging
should not resemble antiretroviral drugs to avoid the perception of receiving treatment for
HIV and being subjected to the stigmatization associated with this. This 21-year-old, unmar-
ried, high engager participant explained: “[They should be packaged] in papers [small plastic zip
lock bags], because if they are put in bottles people will say ‘iii that person,’ they will think you
are taking ARVs, when you aren’t. But when they are in papers people think it’s just these other
medicines. If PrEP drugs were the same antiretroviral drugs that are used for HIV treatment,
women were concerned that being seen with ARVs would lead others to believe that they are
HIV-positive.
In addition to the desire to avoid the appearance of being treated for HIV, women further
preferred that the packaging be discrete enough but “feminine,” resembling drugs that women
routinely use for contraception to keep their use of PrEP confidential. As one participant put
it: “Maybe they should be packaged like contraceptive pills and not like ARVs so that not every-
one should know [that I am using PrEP],” (19 years old, unmarried, high engager).
Dispensing location preferences
Most participants suggested having PrEP available in locations frequented by youth such as
schools would be appealing. Reasons for this included ease of access and comfort in the
absence of adult patients and family members. One participant explained:
“Because most of the youth or let’s say three quarters of the youth we meet at school . . . As
such, it can be good if these drugs are received in schools. Because if we take into consideration
the church there is a threat because the family are also found there so if they can say all youth
should remain behind because there are some drugs to be distributed, with the parents [pres-
ent] it cannot be a good thing but rather at school where we are mostly youth.” (18 years old,
unmarried, low engager)
Other women suggested these services should be offered in youth-friendly spaces like those
established in the Girl Power study. These clinics were set aside from the main facility and
from adult patients, staffed by providers trained in youth-friendly service delivery, and had
young clinic navigators who assisted AGYW access services. This woman explains her prefer-
ence: “A place for the youths to be comfortable getting these drugs, like this one [Girl Power
clinic] it’s just the two of us [the provider and I] in here without any problem,” (22 years old,
married, high engager).
Other participants suggested similar youth-friendly models, sharing the opinion that it
would be beneficial to receive integrated sexual and reproductive health services in tandem
with PrEP services:
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“. . . We could set aside a room where many youths would go access this drug. It would be
appropriate to offer the drug where the other services like social harms or family planning ser-
vices are offered. Therefore, if there would be a special room where someone would be tested
for HIV and given the drug after, then people would be assisted easily.” (20 years old, unmar-
ried, low engager)
Discussion
While there is increasing evidence that PrEP is safe and efficacious in preventing HIV in
diverse populations [13], little is known about the acceptability of and interest in PrEP among
adolescent girls and young women (AGYW) in sub-Saharan Africa. Women in this study were
generally interested in PrEP, and this interest was grounded in a belief that much of their HIV
risk exposure was due to factors that were out of their control, including partners having con-
current relationships, challenges with condom use, and rape. These findings are consistent
with other studies describing AGYW’s interest in emerging biomedical HIV prevention tech-
nologies [14]. Women found the consistent protection of PrEP to be appealing for these rea-
sons, but those women who perceived their HIV risk to be low were less interested in it.
Women were further concerned that the appearance of PrEP packaging and side effects could
lead to negative community perceptions including perceived promiscuity. For these reasons,
women recommended that PrEP be packaged discretely and not carry the appearance of ART.
Finally, women suggested that PrEP should be delivered in youth-friendly settings providing
access to PrEP care, education, and counseling tailored to the youth.
None of the women participating in this study had ever heard of PrEP, but the majority
were interested in using PrEP after learning about its efficacy and safety. High acceptability of
PrEP has been found in similar populations of AGYW [15], and in other populations of adult
women in sub-Saharan Africa. Pregnant and postpartum young women in a study in South
Africa were much more interested in PrEP upon learning about its efficacy, and studies of
other populations of potential PrEP users suggest that PrEP’s acceptability is greatly improved
with education about its efficacy in preventing the acquisition of HIV [16,17]. This suggests
that promoting women’s knowledge of PrEP’s effectiveness will be important in promoting
interest in this prevention technology, and may be critical to help potential users make
informed choices about using PrEP.
The high level of hypothetical PrEP acceptability among AGYW in our study suggests that
there is potential interest in its use. Many AGYW in our study found PrEP appealing because
its use is less sex-act dependent and more personally controlled than condoms. Using PrEP as
an alternative approach to condoms has potential implications for other sexually transmitted
infections (STIs) and unintended pregnancy, something noted by our participants. Once
implemented, the effect of PrEP availability on these outcomes should be monitored and eval-
uated. Despite the importance of monitoring this potential unintended consequence of PrEP
use, previous evidence suggests that PrEP use does not necessarily lead to risk compensation
and cessation of condom use, but rather enhances informed choices [18].
HIV risk awareness may enhance AGYW’s interest in and uptake of PrEP. In this study,
women’s interest in PrEP was highly dependent upon their perceived level of HIV risk.
Although some AGYW did not perceive themselves to be at risk of HIV infection, many of the
same women did express a concern about the possibility of their partners having other sexual
relationships. These findings echo previous studies, which suggest that AGYW may not accu-
rately perceive their HIV risk [19]. In the FEM-PrEP trial, half the sero-conversions happened
in individuals who perceived themselves to be at low risk for HIV[20,21]. Together these find-
ings suggest that raising awareness of PrEP may need to be coupled with counseling on
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potential sources of HIV risk. This finding highlights the need to offer AGYW comprehensive
sexual and reproductive health services to help them better assess their HIV risk and make
informed decisions about the use of PrEP and other HIV prevention products[22].
Our findings also corroborate previous evidence which suggests that offering PrEP in a
youth-friendly environment may promote AGYW’s interest in initiating PrEP [23,24]. Most of
our interviews were conducted among participants who were able to receive other sexual and
reproductive health services in a youth-friendly environment in the context of Girl Power, and
described features of this environment as appealing for PrEP distribution as well. Although
participants had mixed suggestions for the specific location in which to offer PrEP (schools,
hospitals, clinics), they emphasized having a separate youth-friendly space for PrEP and other
sexual and reproductive health care service away from adults.
In addition to offering PrEP in a youth-friendly environment, participants recommended
that PrEP packaging be discrete. Most participants wanted PrEP packaging to appear distinct
from that of typical ART packaging to maintain privacy and avoid the appearance of being
treated for HIV. While discrete packaging may be a short-term approach to mitigating HIV
and PrEP-related stigma, addressing these issues more directly could also be important to facil-
itate AGYW’s utilization of PrEP. Our findings are consistent with those of a study of AGYW
in Kenya [25], which similarly found that discrete packaging of PrEP could serve to mitigate
concerns about stigmatization and consequently motivate PrEP use. The issue of packaging to
ensure integrity, safety and effectiveness of medications is important and should be taken into
account when planning PrEP interventions [22]. Related to concerns about stigma, helping
women understand and manage PrEP-related side effects could also increase the acceptability
of PrEP among AGYW.
Limitations
The results of our study should be interpreted with limitations in mind. Participants lacked
prior knowledge and experience with PrEP use, thus their responses to questions about their
potential interest in PrEP were based on limited information and consideration. Some con-
cerns raised were hypothetical such as certain side effects, and might not bear out in the real
world. Because participants were enrolled in a study in which youth friendly services for HIV
prevention were offered as part of the study intervention, their positive impressions of a
youth-friendly context may reflect social desirability. AGYW were recruited for participation
in the larger trial on a convenience basis through community outreach, participant referral,
and self-referral from urban and peri-urban settings in Lilongwe; as such, the study sample
may not be representative of the target population of sexually active AGYW in the clinic catch-
ment areas, or of AGYW living in rural areas or other regions of Malawi.
Despite these limitations, the findings of this study suggest that PrEP may be an acceptable
method for HIV prevention among sexually active AGYW in Malawi. As PrEP is introduced
in Malawi, it is important to ensure adequate sensitization for the women themselves, their
partners, and communities. Furthermore, its successful introduction may hinge on how PrEP
is offered—the way it is packaged and whether it is delivered in an environment that is sensi-
tive to AGYW concerns. These findings can meaningfully inform the implementation of this
new program for this high-risk population.
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